Jada organized an entire life around one thing: becoming a mother. The road there ran through clinics and embryo donation and the kind of waiting that files a person down to a single exposed nerve. When the child finally arrives, you can feel the shape of the movie most directors would make — the long ordeal rewarded, the credits not far off. Nothing to Lose treats that arrival as a false ending. The fight Jada thought she had won was only the part with a name she could say out loud.

What follows is the harder fight. Her young son falls ill, the diagnosis is a worsening leukemia, and the one thing that can save him is a compatible marrow donor who does not happen to be sitting in a database waiting to be found. The French drama, co-directed by Nawell Madani and Ludovic Colbeau-Justin, is the story of that search and of what the search does to the woman conducting it. It is less interested in the disease than in the machinery a parent meets when she tries to outrun it.

That machinery is where the film locates its real tension. A donor registry is only as deep as the people who ever joined it, and the odds of finding a match drop sharply for patients who are mixed or of minority background, because those are precisely the donors the registries were slowest to recruit. There is no villain in this equation, which is what makes it unbearable. Jada cannot scream at a person who wronged her. She can only push against a system that is indifferent rather than malicious, the kind of obstacle that is far harder to fight and impossible to forgive. The film keeps returning to the question folded into its international title: with nothing left to lose, how far does a parent go.

Madani comes at this role from an unlikely angle, and the casting is the film’s first genuine wager. She built her reputation as a stand-up comedian and made her debut feature, the autobiographical comedy C’est tout pour moi, in 2017. Stand-up is an art of timing and of reading a room in real time; pointing that same instrument at a part with no jokes in it, a register of dread and refusal rather than warmth, is the sort of move that either exposes a performer or remakes one. She wrote the part for herself, from an original idea developed with Pablo Mehler, which means the exposure is deliberate. The audience braced by her name for comfort is meant to be handed fear instead.

Set the film against its ancestors and its ambitions sharpen. French and Belgian cinema has a long, unsentimental habit of placing a parent opposite an institution and declining to look away. The Dardenne brothers did it in Le Fils, watching a father make an impossible moral calculation in close-up. Xavier Legrand’s Custody turned a family-court arrangement into a domestic thriller powered entirely by a parent’s desperation. Jeanne Herry’s Pupille looked clearly at how birth, abandonment and adoption are actually administered by the state, the paperwork under the emotion. Nothing to Lose inherits that lineage and then bends it toward genre, tightening the social-realist study of a woman under pressure into something that ticks like a thriller as the clock winds down.

The risk in that maneuver is obvious. Genre machinery can override realism, and a countdown can flatten a character into a function, a mother reduced to the verb ‘save.’ But the architecture is also the point. By organizing itself around a deadline rather than around a slow decline, the film keeps Jada acting instead of mourning, and converts grief-in-advance into suspense. A chronicle of a sick child asks the audience to brace and weep. A countdown asks them to lean forward. The structural choice, clock rather than calendar, is what lets a subject this heavy keep moving.

It helps that the supporting cast is built to keep Jada from hardening into a saint. Guillaume Gouix supplies a partner to push against; Nicolas Briancon plays the professor managing her son’s case, the human face of a bureaucracy that keeps saying a reasonable, devastating no; Steve Tientcheu rounds out the world she is dragging behind her. The most interesting maternal dramas have never been about a mother’s goodness. They are about the moment her love stops being admirable and becomes a problem for the people around her, and for the systems that were built to help up to a point and no further. The promise here is a film that knows the difference.

There is a specifically European nerve under all of this. The fear the story metabolizes is not the American one about whether a family can afford care. France’s medical system promises something closer to universality, and the dread the film taps is what happens when a system designed to give everyone an equal chance turns out not to, because the underlying pool of donors was never assembled with everyone in mind. That is a live argument in France about representation and who the public institutions were quietly designed around, and the movie smuggles it in through one woman’s panic rather than a speech. The politics arrive as a mother’s problem, which is the only way politics ever really land in a drama.

The gap the film dramatizes is not invented for the screen. Bone-marrow and stem-cell registries skew heavily toward white European donors, and a patient’s best odds of a match come from people of similar ancestry, so the under-recruitment of mixed and minority donors translates directly into longer odds and longer waits for the patients who need them. Donor charities have spent years running registration drives aimed squarely at that imbalance. A film like this can function almost as one of those drives without ever turning into a public-service message, because the abstraction becomes unforgettable the moment it has Jada’s face on it. Whether or not the filmmakers set out to make advocacy, the premise carries it: every viewer who finishes the film knowing what a registry is, and how shallow it gets for some patients, is part of what the story is quietly doing.

Where the film seems to be heading is toward a question it has no intention of answering. Once the legitimate doors have all been tried and closed, every further step Jada takes spends something that belongs to someone else: a stranger’s safety, a rule, a sum of money, a line that was not hers to cross. The work does not appear interested in grading her, in declaring the mother right or reckless. It is interested in how far she gets before the question of right and wrong stops mattering to her at all, and in whether the audience, having been invited to love her, will follow her past the point where they should.

Nothing to Lose - Netflix — Nothing to Lose. Photo: Ulrich Lebeuf/Netflix

That is the reason to watch past the logline. A child’s illness is a setup any viewer can absorb in a single sentence, and a lesser film would spend two hours confirming it. The more demanding story, the one the trailer only gestures at, is about what a society does with a parent who will not accept the answer it keeps giving her, and what that refusal costs once the permitted options are gone. Nothing to Lose is betting that the most frightening thing on screen is not a diagnosis but a mother who has run out of allowed ways to save her son.

Nothing to Lose, released in France as Jusqu’au bout, runs about 99 minutes and arrives worldwide on Netflix on 8 July 2026.